CEA Industries (Nasdaq: BNC) has reached a cooperation agreement with its largest shareholder, YZi Labs, bringing an end to a prolonged governance dispute that had weighed on investor sentiment for months.
The agreement introduces three new directors to the company’s board and formally concludes YZi Labs’ efforts to gain greater influence through a proxy campaign.
Under the arrangement, Ella Zhang, Head of YZi Labs, Investment Partner Alex Odagiu, and Bloq Co-founder Matthew Roszak have joined CEA’s board of directors. Their appointments expand the company’s leadership structure while preserving continuity with existing board members.
The agreement represents a significant step toward stabilizing governance at CEA, which has faced mounting scrutiny since late 2025. Investors have closely monitored the dispute due to its implications for the company’s digital asset strategy and broader corporate direction.
Leadership Changes Take Shape
As part of the transition, Alex Odagiu will assume the role of interim president while the company conducts a search for a permanent chief executive officer. A dedicated committee has been established to oversee the recruitment process.
Current CEO David Namdar, who announced plans to step down earlier this year, will remain in his position until a successor is selected. The arrangement is intended to ensure operational continuity during a period of significant organizational change.
Key outcomes of the agreement include:
- Appointment of three new directors to the board.
- Alex Odagiu named interim president.
- Withdrawal of YZi Labs’ proxy-related actions.
- Formation of a committee to identify a new CEO.
- Continuation of David Namdar’s leadership during the transition.
The resolution removes a major source of uncertainty for shareholders and positions the company to focus on long-term strategic objectives.
Governance Battle Finally Settled
The dispute traces back to November 2025, when YZi Labs launched an aggressive campaign seeking greater board representation and governance reforms. The shareholder argued that CEA had failed to capitalize on market opportunities despite securing a $500 million private placement and operating during a period when BNB experienced notable gains.
YZi Labs also questioned the company’s governance framework and its relationship with investment manager 10X Capital. Concerns intensified after CEA adopted a shareholder rights plan, commonly referred to as a “poison pill,” a mechanism designed to make hostile takeovers more difficult and costly.
Tensions escalated further when CEA filed legal action against 10X Capital, seeking to terminate their asset management arrangement and recover fees paid under the agreement.
Markets responded positively to news of the settlement. CEA shares climbed 8.35% to close at $2.27. Despite the rally, the stock remains down 64.7% since the beginning of the year. Meanwhile, BNB traded at $575.86, reflecting a 2.6% decline over the previous 24 hours and a year-to-date drop of approximately 33%.
With the proxy battle now resolved, investors will be watching whether the refreshed leadership team can restore confidence, improve governance, and create a clearer path forward for the company.
Sources & Methodology
Primary-source standard: Market-moving facts should link to original data releases, regulator notices, company filings or official project announcements whenever available. Secondary reporting is used for additional context, not as a substitute for original evidence.
Page last reviewed: